Using ankle-brachial index to detect peripheral arterial disease: Prevalence and associated risk factors in a random population sample

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 17, Issue 1, 2007, Pages 41-49

  Carbayo, Julio A ^a   Divisón, Juan A ^b   Escribano, Julio ^c   López Abril, Juan ^b   López de Coca, Enrique ^b   Artigao, Luis M ^b   Martínez, Esperanza ^c   Sanchis, Carlos ^b   Massó, Javier ^b   Carrión, Lucinio ^b  

^a Medical Corps   (Spain)

^b Primary Health Care Centre   (Spain)

^c UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

Ankle brachial index; Arteriosclerosis; Epidemiology; Peripheral arterial disease; Risk factors

Indexed keywords

ADULT; AGED; ANKLE; ARTICLE; BLOOD PRESSURE; BRACHIAL ARTERY; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; PHYSIOLOGY; PREVALENCE; RISK FACTOR; SEXUAL DEVELOPMENT; VASCULARIZATION;

ADULT; AGED; ANKLE; BLOOD PRESSURE; BRACHIAL ARTERY; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PREVALENCE; RISK FACTORS; SEX CHARACTERISTICS;

EID: 33845496468     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2005.08.009     Document Type: Article

References (27)

1. Wood D., De Backer G., Faergeman O., Graham I., Mancia G., Pyörälä K., et al. Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis 140 (1998) 199-270
2. López A.D., and Murray C.J.L. The global burden of disease, 1990-2020. Nat Med 4 (1998) 1241-1243
3. Greenland P., Abrams J., Aurigemma G.P., Bond M.G., Clark L.T., Criqui M.H., et al. Prevention Conference V. Beyond secondary prevention: identifying the high-risk patient for primary prevention. Non-invasive tests of atherosclerotic burden. Circulation 101 (2000) e16-e22
4. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
5. Smith Jr. S.C., Blair S.N., Criqui M.H., Fletcher G.F., Fuster V., Gersh B.J., et al. Preventing heart attack and death in patients with coronary disease. Circulation 92 (1995) 2-4
6. Newman A.B., Shemanski L., Manolio T.A., Cushman M., Mittelmark M., Polak J.F., et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol 19 (1999) 538-545
7. Hooi J.D., Kester A.D., Stoffers H.E., Rinkens P.E., Knottnerus J.A., and van Ree J.W. Asymptomatic peripheral arterial occlusive disease predicted cardiovascular morbidity and mortality in a 7-year follow-up study. J Clin Epidemiol 57 (2004) 294-300
8. McDermott M.M. Peripheral arterial disease: epidemiology and drug therapy. Am J Geriatr Cardiol 11 (2002) 258-266
9. Resnick H.E., Lindsay R.S., McDermott M.M., Devereux R.B., Jones K.L., Fabsitz R.R., et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation 109 (2004) 733-739
10. Martínez E., Puras A., Escribano J., Sanchis C., Carrión L., Artigao M., et al. Angiotensin-converting enzyme (ACE) gene polymorphisms, serum ACE activity and blood pressure in a Spanish-Mediterranean population. J Hum Hypertens 14 (2000) 131-135
11. American Society of Hypertension. Recommendations for routine blood pressure measurement by indirect cuff sphygmomanometry. Am J Hypertens 5 (1992) 207-209
12. Hirsch A.T., Criqui M.H., Treat-Jacobson D., Regensteiner J.G., Creager M.A., Olin J.W., et al. Peripheral arterial disease detection, awareness and treatment in primary care. JAMA 286 (2001) 1317-1324
13. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 157 (1997) 2413-2446
14. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20 (1997) 1183-1197
15. Spanish Ministry of Health, Spanish Cardiology Society and Spanish Atherosclerosis Society. Control of blood cholesterol in Spain 2000. An instrument for cardiovascular disease prevention. Clin Invest Arterioscler 12 (2000) 125-152
16. SEEDO'2000 consensus for the evaluation of overweight and obesity and the establishment of criteria for therapeutic intervention. Med Clin (Barc) 115 (2000) 587-597
17. Fernández-Miranda C., Paz M., Aranda J.L., Fuertes A., and Gómez de la Cámara A. Chronic Chlamydia pneumoniae infection in patients with coronary disease. Relation with increased fibrinogen values. Med Clin (Barc) 119 (2002) 561-564
18. Newman A.B., Siscovick D.S., Manolio T.A., Polak J., Fried L.P., Borhani N.O., et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation 88 (1993) 837-845
19. McDermott M.M., Greenland P., Liu K., Guralnik J.M., Criqui M.H., Dolan M.C., et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA 286 (2001) 1.599-1.606
20. Murabito J.M., Evans J.C., Nieto K., Larson M.G., Levy D., and Wilson W.F. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J 143 (2002) 961-965
21. Weitz J.I., Byrne J., Clagett G.P., Farkouh M.E., Porter J.M., Sackett D.L., et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 94 (1996) 3026-3049
22. Buitron-Granados L.V., Martinez-Lopez C., and Escobedo de la Pena J. Prevalence of peripheral arterial disease and related risk factors in an urban Mexican population. Angiology 55 (2004) 43-51
23. Selvin E., and Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States. Results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 110 (2004) 738-743
24. Haltmayer M., Mueller T., Horvath W., Luft C., Poelz W., and Haidinger D. Impact of atherosclerosis risk factors on the anatomical distribution of peripheral arterial disease. Int Angiol 20 (2001) 200-207
25. Kannel W.B. Influence of fibrinogen on cardiovascular disease. Drugs 54 Suppl. 3 (1997) 32-40
26. Vicente I., Lahoz C., Taboada M., García A., San Martín M.A., Terol I., et al. Prevalence of an abnormal ankle-brachial index in relation to the cardiovascular risk estimated by the Framingham function. Med Clin (Barc) 124 (2005) 641-644
27. Grundy S.M., Cleeman J.I., Merz C.N., Brewer Jr. H.B., Clark L.T., Hunninghake D.B., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation 110 (2004) 227-239